Treatment of Methamphetamine Dependence: Does Treatment Work?
|
|
- Crystal Parker
- 5 years ago
- Views:
Transcription
1 Treatment of Methamphetamine Dependence: Does Treatment Work? Mary Lynn Brecht, Ph.D. Richard A. Rawson, Ph.D Semel Institute for Neuroscience and Human Behavior David Geffen School of Medicine University of California at Los Angeles Supported by: National Institute on Drug Abuse (NIDA) Pacific Southwest Technology Transfer Center (SAMHSA) International Network of Treatment and Rehabilitation Resource Centres (UNODC)
2 160, , , ,000 80,000 60,000 40,000 20,000 U.S. Treatment Admissions for Primary Methamphetamine Abuse
3 Are Treatment Outcomes for Individuals with Methamphetamine Dependence Different than for Other Drug Dependencies?
4 Meth Treatment Effectiveness? A pervasive rumor has surfaced in many geographic areas with elevated MA problems: MA users are virtually untreatable with negligible recovery rates. Rates from 5% to less than 1% have been quoted in newspaper articles and reported in conferences. Representatives for some commercial treatment concerns have suggested there are no effective treatments for methamphetamine dependence.
5 CA Treatment System Outcomes % Using in Past 30 Days by Type of Drug admission discharge Percent Alcohol Heroin/op Coc/crack Marijuana Meth/amph Other Based on 81,382 episodes of treatment Source: ISAP Evaluation of CalOMS, Rawson et al., 2008
6 % Completing Treatment-- CA SACPA Meth Users 100 Percent Alcohol Heroin/op Coc/crack Marijuana Meth/amph Source: Anglin et al., Criminal Justice Treatment Admissions, J. of Psychoactive Drugs, 2007
7 Do Methamphetamine Users Respond Differently to Treatment than Cocaine Users?
8 Comparability of Treatment Outcome: Cocaine vs Methamphetamine Alice Huber, Walter Ling and Richard Rawson * Cohorts of methamphetamine dependent patients (N=500) and cocaine dependent patients (N=224) treated with a standardized, outpatient treatment protocol (Matrix Model) at the same clinic site, by the same staff over the same time period, demonstrated very similar treatment response on virtually all treatment participation and outcome measures * Jnl of Addictive Diseases, 18, 1997, P
9
10 Differences between methamphetamine users and cocaine users in treatment Amy L. Copeland and James L. Sorensen* The two populations did not differ in treatment adherence, as measured by clinic attendance, drug-free urines, and successful completion of treatment. * Drug and Alcohol Dependence, Volume 62, March 2001, Pages 91-95
11 Treatment response by primary drug of abuse: Does methamphetamine make a difference? Bill Luchansky, Antoinette Krupski, and Kenneth Stark* For both adults and youth, the results showed that across outcomes, there were few differences between MA users and users of other hard drugs, whereas there were consistent differences between MA users and users of alcohol and marijuana. Alcohol and marijuana users tended to have more positive outcomes than the other groups. *Journal of Substance Abuse Treatment Vol 32, 2007, Pages 89-96
12 Summary Treatment outcome data indicate that psychosocial treatments used in community treatment programs produce comparable outcomes for methamphetamine dependent individuals and those with other forms of drug dependency
13 Treatments for Stimulant-use Disorders with Empirical Support Cognitive-Behavioral Therapy (CBT) Community Reinforcement Approach Contingency Management 12 Step Facilitation All have empirical support for the treatment of cocaine dependence
14 Methamphetamine Treatment: Controlled Clinical Trials Cognitive Behavioral Therapy Contingency Management Matrix Model
15 CBT: Basic Assumptions Emphasizes cognitive aspects of drug/alcohol use as learned behavior Role of cognitions in abstinence Treatment is a teaching process, coaching and reinforcing; therapist is a teacher/coach No assumption of underlying psychopathology New, alternative behaviors must be established Can be delivered in group or individual settings
16 Contingency Management A technique employing the systematic delivery of positive reinforcement for desired behaviors. In the treatment of methamphetamine dependence, vouchers or prizes can be earned for submission of methamphetamine-free urine samples.
17 Cognitive Behavioral Therapy and Contingency Management for Stimulant Dependence Participants Stimulant-dependent individuals (n = 171). Intervention CM, CBT, or combined CM and CBT, 16-week treatment conditions. CM condition participants received vouchers for stimulant-free urine samples. CBT condition participants attended three 90-minute group sessions each week.. Results CM procedures produced better retention and lower rates of stimulant use during the study period Self-reported stimulant use was reduced from baseline levels at all follow-up points for all groups and urinalysis data did not differ between groups at follow-up. While CM produced robust evidence of efficacy during treatment application, CBT produced comparable longer-term outcomes. There was no evidence of an additive effect when the two treatments were combined. The response of cocaine and methamphetamine users appeared comparable. Conclusions: This study suggests that CM is an efficacious treatment for reducing stimulant use and is superior during treatment to a CBT approach. CBT also reduces drug use from baseline levels and produces comparable outcomes on all measures at follow-up. Rawson, RA et al. Addiction, Jan 2006
18 FIGURE 1. Program Retention by Group
19 FIGURE 2. Stimulant free Urine Samples by Group Mean Number Cognitive- Behavioral Therapy (CBT) Contingency Management (CM) CBT+CM Group (F = 10.2, df = 2, P < )
20 FIGURE 3. Self-Reported Stimulant Use Mean Days of Stimulant Use Cognitive- Behavioral Therapy (CBT) Contingency Management (CM) CBT+CM Baseline 17 Weeks 26 Weeks 52 Week
21 Contingency Management: An Evidence-Based Component of Methamphetamine Use Disorder Treatments* *Roll, J. Contingency management: an evidence based component of methamphetamine use disorder treatments. Addiction. 2007;102 (Suppl. 1):
22 Contingency Management for Treatment of Methamphetamine Dependence Design: RTC Method: 113 patients diagnosed with methamphetamine abuse or dependence were randomly assigned to receive either treatment as usual (TAU) or TAU plus contingency management. Results indicate that both groups were retained in treatment for equivalent times but those in the combined group accrued more abstinence and were abstinent for a longer period of time. These results suggest that contingency management has promise as a component in methamphetamine use disorder treatment strategies. * Roll JM, Petry NM, Stitzer ML, et al: Contingency management for the treatment of methamphetamine use disorders. Am J Psychiatry 163(11): , 2006
23
24 Mean weeks of consecutive abstinence CM Control
25 Matrix Model Is a manualized, 16-week, non-residential, psychosocial approach used for the treatment of drug dependence. Manuals Can be downloaded at SAMHSA.gov Designed to integrate several interventions into a comprehensive approach. Elements include: Individual counseling Cognitive behavioral therapy Motivational interviewing Positive reinforcement for behavior change Family education groups Urine testing Participation in 12-step programs
26 Treatment Components of the Matrix Model Individual Sessions Early Recovery Groups Relapse Prevention Groups Family Education Group 12-Step Meetings Social Support Groups Relapse Analysis Urine Testing
27 The CSAT Methamphetamine Treatment Project A Multi-site Trial of a Manualized Psychosocial Protocol for the Treatment of Methamphetamine Dependence Rawson, R.A., Marinelli-Casey, P., Anglin, M.D., Dickow, A., Frazier, Y., Gallagher, C., Galloway, G.P., Herrell, J., Huber, A., McCann, M.J., Obert, J., Pennell, S., Reiber, C., Vandersloot, D., Zweben, J., and the Methamphetamine Treatment Project Corporate Authors. (2004). A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction, 99,
28 Mean Number of Weeks in Treatment mean number of visits Billings Concord CostaMesa Hayward Honolulu SanDiego SanMateoODAS Matrix TAU SanMateoPyra SITE
29 Mean Number of UA s that were MA-free during treatment mean number of MA-free UA's Billings Concord CostaMesa Hayward Honolulu SanDiego SanMateoODAS Matrix TAU SanMateoPyra SITE
30 Urinalysis Results Results of Ua Tests at Discharge, 6 months and 12 Months post admission ** Matrix Group TAU Group D/C: 66% MA-free 65% MA-free 6 Ms: 69% MA-free 67% MA-free 12 Ms: 59% MA-free 55% MA-free **Over 80% follow up rate in both groups at all points
31 Predictors of In-treatment Performance and Post-Treatment Outcomes in a Methamphetamine- Dependent Adults
32 Predictors of Long-Term Abstinence Predictors of no MA use at treatment discharge, and at the 6- and 12-mos follow-ups includes: MA use of < 15 days at baseline, Lifetime MA use of < 2 years No previous drug abuse treatment Providing 3 consecutive MA-free UAs during treatment
33 Thank you
Intensive Outpatient Alcohol and Drug Treatment Program
THE MATRIX MODEL FOR TEENS AND YOUNG ADULTS Intensive Outpatient Alcohol and Drug Treatment Program SCOPE AND SEQUENCE Jeanne L. Obert, MSM, LMFT Michael J. McCann, MA Jeremy Martinez, MD CONTENTS Introduction
More informationThe Matrix Model in the New Healthcare World: Implementing EBPs
The Matrix Model in the New Healthcare World: Implementing EBPs Ahndrea Weiner M.S., LMFT, LPCC Director of Training Matrix Institute on Addictions History of The Matrix Model Traveling Back to the 1980
More informationEvidence-Based Practice: Psychosocial Interventions
Evidence-Based Practice: Psychosocial Interventions Maxine Stitzer, Ph.D. Johns Hopkins Univ SOM NIDA Blending Conference June 3, 2008 Cincinnati, Ohio Talk Outline What is an evidence-based practice?
More informationBehavioral Therapies for Methamphetamine Use
Behavioral Therapies for Methamphetamine Use Will M. Aklin, PhD National Institute on Drug Abuse Division of Therapeutics and Medical Consequences June 27, 2017 1 Behavioral Therapy Development Program
More informationTweaking 12-Step : the potential role of 12-Step self-help group involvement in methamphetamine recovery
REPORT Tweaking 12-Step : the potential role of 12-Step self-help group involvement in methamphetamine recovery Dennis M. Donovan 1,2 & Elizabeth A. Wells 3 Alcohol and Drug Abuse Institute, University
More informationThe role of behavioral interventions in buprenorphine treatment of opioid use disorders
The role of behavioral interventions in buprenorphine treatment of opioid use disorders Roger D. Weiss, MD Harvard Medical School, Boston, MA, McLean Hospital, Belmont, MA, USA Today s talk Review of studies
More informationGrant Writing Toolkit
The Matrix Model for Teens and Young Adults Intensive Outpatient Alcohol and Drug Treatment Program Grant Writing Toolkit For more information about this program, visit or call Contents The Matrix Model
More information2/19/18. Today s talk. Today s talk. The Role of Behavioral Interventions in Buprenorphine Treatment of Opioid Use Disorders
The Role of Behavioral Interventions in Buprenorphine Treatment of Opioid Use Disorders Roger D. Weiss, MD Chief, Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA Professor of Psychiatry,
More informationISAP Training Update
ISAP Training Update CADPAAC Quarterly Meeting, January 2010 UCLA Integrated Substance Abuse Programs (ISAP) Walter Ling, MD, Director Richard A. Rawson, PhD, Associate Director Pacific Southwest Addiction
More informationA systematic review of cognitive and behavioural therapies for methamphetamine dependence
Drug and Alcohol Review (May 2008), 27, 309 317 A systematic review of cognitive and behavioural therapies for dependence NICOLE K. LEE 1 & RICHARD A. RAWSON 2 1 Clinical Research Program, Turning Point
More informationOverview of MET/CBT 5 Adoption
Overview of MET/CBT 5 Adoption Randolph Muck, M.Ed. Substance Abuse and Mental Health Services Administration Rockville, MD and Michael L. Dennis, Ph.D., Melissa Ives, M.S.W. Chestnut Health Systems, Bloomington,
More informationBest Practice Models for Opioid Treatment Programs Motivated Stepped Care: An Adaptive Treatment Approach. Van L. King, MD
Best Practice Models for Opioid Treatment Programs Motivated Stepped Care: An Adaptive Treatment Approach Van L. King, MD UT Health, Department of Psychiatry Grand Rounds November 15, 2016 Addiction Treatment
More informationOverview of. Treatment Outcome Studies from DATOS
Drug Abuse Treatment Outcome (Funded by NIDA) Overview of Treatment Outcome from DATOS Charts Prepared & Released for Public Use by Dwayne Simpson (TCU), Robert Hubbard (NDRI-NC), Douglas Anglin (UCLA),
More informationImproving Outcomes in Methadone Treatment
Improving Outcomes in Methadone Treatment Cognitive/Behavioral Treatment Contingency Management Michael J. McCann, MA Matrix Institute on Addictions COMP Symposium September 11, 2007 Overview of Presentation
More informationTreatment Options Methamphetamine Symposium Lori Miller, LCSW Health Program Manager
Department of Health & Human Services Division of Behavioral Health Services Alcohol & Drug Services Treatment Options Methamphetamine Symposium Lori Miller, LCSW Health Program Manager 1 Service Languages
More informationRachel Gonzales-Castaneda, PhD, MPH
Rachel Gonzales-Castaneda, PhD, MPH rcastaneda@apu.edu; rachelmg@ucla.edu EDUCATION/TRAINING University of California Los Angeles 2007 Doctorate of Philosophy (PhD) Public Health Minor in Health Psychology
More informationFACT SHEET. Women in Treatment
FACT SHEET Women in Treatment February 2011 The data in this fact sheet are based on clients in publicly funded and/or monitored alcohol and other drug treatment services in California during State Fiscal
More informationInternet Delivered Counselling for Gambling Disorder
Internet Delivered Counselling for Gambling Disorder Darren R. Christensen, PhD Chair in Gambling, Alberta Gambling Research Institute, Associate Professor, Faculty of Health Science, University of Lethbridge
More information3/21/2015. Leonardo Andrade, Ph.D. Westfield State University
Leonardo Andrade, Ph.D. Westfield State University Evidence based behavioral treatment for drug abuse Theoretical foundation of CM is based on operant conditioning principles Contingencies associated with
More informationEpidemiology of Addiction
Epidemiology of Addiction M.-L. Brecht UCLA Integrated Substance Abuse Programs California Society of Addiction Medicine Review Course Oct. 24, 2008 The presenter has no conflicts related to this material.
More informationOverview of Treatment Engagement Findings from DATOS
Drug Abuse Outcome Studies (Funded by NIDA) Overview of Engagement Findings from DATOS Charts Prepared & Released for Public Use by Dwayne Simpson (TCU), Robert Hubbard (NDRI-NC), Douglas Anglin (UCLA),
More informationPsychosocial interventions for cannabis use disorder
Psychosocial interventions for cannabis use disorder Peter Gates 1, Pamela Sabioni 2, Jan Copeland 1, Bernard Le Foll 2, & Linda Gowing 3 1 NCPIC, UNSW Medicine; 2 Centre for Addiction and Mental Health,
More informationThe Importance of Psychological Treatment and Behavioral Support
The Importance of Psychological Treatment and Behavioral Support Michael W. Otto, PhD Department of Psychological and Brain Science Boston University Conflicts and Acknowledgements No industry funding
More informationReferral to Treatment: Utilizing the ASAM Criteria
Referral to Treatment: Utilizing the ASAM Criteria AOAAM Essentials in Addiction Medicine October 22, 2016 East Lansing, MI Stephen A. Wyatt, DO Medical Director, Addiction Medicine Behavioral Health Service
More informationA COMPARISON OF FIVE REINFORCEMENT SCHEDULES FOR USE IN CONTINGENCY MANAGEMENT-BASED TREATMENT OF METHAMPHETAMINE ABUSE
The Psychological Record, 2006, 56, 67-81 A COMPARISON OF FIVE REINFORCEMENT SCHEDULES FOR USE IN CONTINGENCY MANAGEMENT-BASED TREATMENT OF METHAMPHETAMINE ABUSE JOHN M. ROLL, ALICE HUBER, RUTHL YN SODANO,
More informationCSAM-SCAM Fundamentals. Cocaine Basics. Presentation provided by David C. Marsh MD CCSAM
CSAM-SCAM Fundamentals Cocaine Basics Presentation provided by David C. Marsh MD CCSAM Chronic Illness Relapsing & Remitting in Course Genetic Predisposition Individual Choice a Factor Environmental Influence
More informationImplementation of Cognitive-Behavioral Substance Abuse Treatment in Sub-Saharan Africa: Treatment Engagement and Abstinence at Treatment Exit
Implementation of Cognitive-Behavioral Substance Abuse Treatment in Sub-Saharan Africa: Treatment Engagement and Abstinence at Treatment Exit The Harvard community has made this article openly available.
More informationTrigger. Myths About the Use of Medication in Recovery BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS
BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module VI Counseling Buprenorphine Patients Myths About the Use of Medication in Recovery! Patients are still addicted!
More informationDifficulties experienced by methamphetamine clients, with regard to cognitive functioning,
SEPTEMBER 2006 VOLUME 9, ISSUE 8 PLEASE COPY OR POST SERIES 23 Northwest Frontier Addiction Technology Transfer Center 810 D Street NE Salem, OR 97301 Phone: (503) 373-1322 FAX: (503) 373-7348 A project
More informationCHAPTER 27: BEHAVIOR ANALYSIS AND TREATMENT OF DRUG ADDICTION
CHAPTER 27: BEHAVIOR ANALYSIS AND TREATMENT OF DRUG ADDICTION Fisher ch.27 Drug addiction is a very prevalent issue in the current United States society. The substance abuse treatments that are available
More informationCO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS INTEGRATING COMBINED THERAPIES (ICT) FOR CO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS
INTEGRATING COMBINED THERAPIES (ICT) FOR CO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS 2009 MARRCH CONFERENCE 22 October 2009 CO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS 1. Common in the
More informationAs substance abuse treatment agencies become more familiar with Motivational
SEPTEMBER 2007 VOLUME 10, ISSUE 9 PLEASE COPY OR POST SERIES 27 Northwest Frontier Addiction Technology Transfer Center 810 D Street NE Salem, OR 97301 Phone: (503) 373-1322 FAX: (503) 373-7348 A project
More informationROSC & MAT II: Opioid Treatment Services
ROSC & MAT II: Opioid Treatment Services September 23, 2015 Stan DeKemper Executive Director Indiana Credentialing Association on Addiction and Drug Abuse 1 GOALS Review medication assisted recovery Identify
More informationFinal Evaluation Report
The Louisiana Access to Recovery Project Final Evaluation Report Access to Recovery II: 2007-2010 Prepared for: Louisiana Department of Health and Hospitals (DHH) Office of Behavioral Health Author: Laurel
More informationA 5-volume series on promising new brief therapies for teens who use marijuana CYT. Cannabis Youth Treatment Series
A 5-volume series on promising new brief therapies for teens who use marijuana CYT Cannabis Youth Treatment Series U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services
More informationHealth Risk Reduction Projects Study Will Follow Children with HIV+ Mothers into Early Adolescence/Young Adulthood
UCLA Integrated Substance Abuse Programs ISAP News Volume 6, Issue 1 June 2008 www.uclaisap.org Health Risk Reduction Projects Study Will Follow Children with HIV+ Mothers into Early Adolescence/Young
More informationEffects of Drugs on Dopamine Release. Methamphetamine: Current Knowledge about Effects and Treatments
% of Basal Release % of Basal Release % Basal Release % of Basal Release Methamphetamine: Current Knowledge about Effects and Treatments Richard A. Rawson, Ph.D, Research Professor Center for Behavior
More informationEnsuring/Creating Effective Treatment for Drug Abusing Parents. TTaylor Behavioral Health
Ensuring/Creating Effective Treatment for Drug Abusing Parents Nicolas Taylor, Ph.D., CAC III TBH TTaylor Behavioral Health 242 West Main Street, #9 Montrose, CO 81401 970-249-44484448 nt.tbh@montrose.net
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This fact sheet discusses research findings on effective treatment approaches for drug abuse and addiction. If you re seeking treatment, you can call the Substance
More informationYOUTH ADDICTIONS E-THERAPY PROGRAM SPONSORED BY FEDERAL GRANT
YOUTH ADDICTIONS E-THERAPY PROGRAM SPONSORED BY FEDERAL GRANT Strengthening Teens Empowering Parents 09/24/08 AOCMHP Meeting Slide 1 What is STEP? Alcohol and/or drug education, prevention and intervention
More informationManagement Options for Opioid Dependence:
Management Options for Opioid Dependence: Policy Implications and Recommendations Dan Ollendorf, PhD Sarah Jane Reed, MSc New England CEPAC Goal: To improve the application of evidence to guide practice
More informationPOLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE MARK DUNCAN, MD November 8, 2018 SPEAKER
More informationCTN Research Update. National Advisory Council on Drug Abuse May 8, Betty Tai, Ph.D. Center for the Clinical Trials Network
CTN Research Update National Advisory Council on Drug Abuse May 8, 2013 Betty Tai, Ph.D. Center for the Clinical Trials Network CTN Steering Committee NIDA - CCTN NIDA National Drug Abuse Treatment Clinical
More informationLogan House: A Project Snapshot
Logan House: A Project Snapshot by Dave Warby ATCA symposium 11th & 12th October 2010 Logan House Pre-Release Program (DO IT) AOD & AOD Youth Program QIDDI Gambling Help Holyoake Driving With Care Interlock
More informationIntegrated Addiction Services Glasgow City. Christine Laverty Head of Addiction Services North West Glasgow April 2014
Integrated Addiction Services Glasgow City Christine Laverty Head of Addiction Services North West Glasgow April 2014 Many drug users have a myriad of health and social problems which require interventions
More informationCANDIS. A Marijuana Treatment Program for Youth and Adults SCOPE AND SEQUENCE. An Evidence-Based Program from
A Marijuana Treatment Program for Youth and Adults SCOPE AND SEQUENCE An Evidence-Based Program from For more information about this program, visit hazelden.org/bookstore or call 800-328-9000. Introduction
More informationAdvances in Clinical Research for Prescription Opioid Dependence
Advances in Clinical Research for Prescription Opioid Dependence Scott E. Provost, M.M., M.S.W. Jennifer Sharpe Potter, Ph.D., M.P.H. Roger D. Weiss, M.D. Objectives To learn about: 1. the prevalence of
More informationAlcohol Users in Treatment
October 2009 Fact Sheet Alcohol Users in Treatment The data in this fact sheet are based on admissions 1 and discharges from publicly funded alcohol and narcotic treatment services in California during
More informationRelapse Prevention Strategies in Outpatient Substance Abuse Treatment
Psychology of Addictive Behaviors 1993, Vol. 7, No. 2, 85-95 Copyright 1993 by the Educational Publishing Foundation 0893-164X/93/S3.00 Relapse Prevention Strategies in Outpatient Substance Abuse Treatment
More informationNeurobiological Advances in Addiction Science: Implications For Treatment Nora D. Volkow, M.D. Director
Neurobiological Advances in Addiction Science: Implications For Treatment Nora D. Volkow, M.D. Director @NInews Concentration ) Dopamine (nm) Drugs and Natural Rewards ACTIVATE Dopamine in Reward Regions
More informationPsychopharmacology Practice Guidelines For Individuals With Co-Occurring Substance Abuse (SA) And Serious Mental Illness (SMI)
Psychopharmacology Practice Guidelines For Individuals With Co-Occurring Substance Abuse (SA) And Serious Mental Illness (SMI) Overview The results of the most recent national household survey found that
More informationEngaging Young People with Addiction in Treatment
Engaging Young People with Addiction in Treatment James McKowen, Ph.D. Addiction Recovery Management Service (ARMS) Orlando, FL 2016 Disclosures Neither I nor my spouse/partner has a relevant financial
More informationDenise Walker, Ph.D.
Interventions for Adolescents: State of the Science and Looking Ahead Denise Walker, Ph.D. University of Washington Research Associate Professor, School of Social Work Co-Director, Innovative Programs
More informationNew Zealand Context. Anna Nelson & Ashley Koning
Contingency Management in the New Zealand Context Anna Nelson & Ashley Koning Acknowledgements All 126 of those who participated in the Introduction to Contingency Management workshops held in Christchurch,
More informationBlending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings
William R. Miller, Ph.D. The University of New Mexico Have you noticed: that in multisite trials (like CTN) of treatments that are already evidence-based even under highly controlled, supervised, manual
More informationMOTIVATIONAL INTERVIEWING. Evidence-Based Behavioral Therapy for Addictions. Therapies
Evidence-Based Behavioral Therapy for Addictions Chris Farentinos, MD, MPH, CADC II Director Behavioral Health Legacy Therapies Motivational Interviewing (MI) Cognitive Behavioral Therapy (CBT) Dialectical
More informationSuzette Glasner-Edwards, Ph.D.
California Medical Evaluators 11620 Wilshire Blvd. Suite 340 Los Angeles, CA 90025 Ph: 888.853.7944 Fx: 213.377.5152 EDUCATION Post-Doctoral Fellowship Suzette Glasner-Edwards, Ph.D. Veterans Healthcare
More informationHIV/AIDS and Drug Use in the United States: A case for Strategic Planning
HIV/AIDS and Drug Use in the United States: A case for Strategic Planning Steve Shoptaw, Ph.D. UCLA Integrated Substance Abuse Programs Friends Research Institute, Inc. May 19, 2004 Main Points AIDS-related
More informationEvaluation of a community-based integrated heroin addiction treatment model in Chinese patients
/, 2017, Vol. 8, (No. 33), pp: 54046-54053 Evaluation of a community-based integrated heroin addiction treatment model in Chinese patients Hong-He Zhang 1,2, Lin-Xiang Tan 1, Wei Hao 1 and Qi-Jian Deng
More informationCSAT Publications -- TAP 25, The Impact of Substance Abuse Treatment on Employment Outcomes Among AFDC Clients in Washington State
CSAT Publications -- TAP 25, The Impact of Substance Abuse Treatment on Employment Outcomes Among AFDC Clients in Washington State Table of Contents The Impact of Substance Abuse Treatment on Employment
More informationRobert Walker, M.S.W., L.C.S.W. University of Kentucky Center on Drug and Alcohol Research
Robert Walker, M.S.W., L.C.S.W. University of Kentucky Center on Drug and Alcohol Research Science and dogma The Federal government has issued mandates to states to use evidence based practices for treating
More informationUCLA Integrated Substance Abuse Programs. Biennial Report. Fiscal Years 2005 and (July 1, 2004, to June 30, 2006) Director Walter Ling, M.D.
UCLA Integrated Substance Abuse Programs Biennial Report Fiscal Years 2005 and 2006 (July 1, 2004, to June 30, 2006) Director Walter Ling, M.D. Associate Directors M. Douglas Anglin, Ph.D. Richard A. Rawson,
More informationV. EVIDENCE-BASED APPROACHES TO TREATING ADOLESCENT SUBSTANCE USE DISORDERS
V. EVIDENCE-BASED APPROACHES TO TREATING ADOLESCENT SUBSTANCE USE DISORDERS R esearch evidence supports the effectiveness of various substance abuse treatment approaches for adolescents. Examples of specific
More informationCenterstone Research Institute
American Addiction Centers Outcomes Study 12 month post discharge outcomes among a randomly selected sample of residential addiction treatment clients Centerstone Research Institute 2018 1 AAC Outcomes
More informationCurrent Trends and Future Directions in the Study of Psychosocial Treatments for Pathological Gambling David M. Ledgerwood and Nancy M.
CURRENT DIRECTIONS IN PSYCHOLOGICAL SCIENCE Current Trends and Future Directions in the Study of Psychosocial Treatments for Pathological Gambling David M. Ledgerwood and Nancy M. Petry Department of Psychiatry,
More informationISAP Initiates Training Program for UN Global Network of Drug Abuse Treatment Centers
UCLA Integrated Substance Abuse Programs ISAP News Volume 4, Issue 2 December 2006 ISAP Initiates Training Program for UN Global Network of Drug Abuse Treatment Centers By Anne Bellows, UNODC Project Director
More informationAcknowledgements. Substance Abuse and the Child Protection System. Substance Abuse and the Child Protection System
Preliminary Outcomes from the Building Stronger Families Program: Ecological Treatment for Co-Occurring Parental Substance Abuse and Child Maltreatment Cindy M. Schaeffer, Ph.D. 1 Cynthia C. Swenson, Ph.D.
More informationImplementing EBPs in a Community Treatment Program: Beyond Instruction
Implementing EBPs in a Community Treatment Program: Beyond Instruction APA Convention San Francisco August 17, 2007 Joan E. Zweben, Ph.D. Executive Director The 14 th Street Clinic & EBCRP Clinical Professor
More informationTobacco Research at NIDA: Neuroscience, Treatment and Regulatory-related studies
% of Basal Release Dopamine (nm) Wilson M. Compton, MD, MPE Deputy Director, National Institute on Drug Abuse Tobacco Research at NIDA: Neuroscience, Treatment and Regulatory-related studies Themes for
More informationCounselors Treatment Manual READ ONLINE
Counselors Treatment Manual READ ONLINE Counselor s treatment manual: Matrix intensive - Counselor s treatment manual: Matrix intensive outpatient treatment for people with stimulant use disorders [SAMHSA,
More informationOnline publication date: 19 April 2010 PLEASE SCROLL DOWN FOR ARTICLE
This article was downloaded by: [Smout, Matthew F.] On: 21 April 2010 Access details: Access Details: [subscription number 921432012] Publisher Routledge Informa Ltd Registered in England and Wales Registered
More informationModels of good practice in drug treatment in Europe. Project group
Models of good practice in drug treatment in Europe ( moretreat 2006329 ) Project group Hamburg, London, Rome, Stockholm, Vienna, Warsaw, Zurich Project duration: 17 months from April 2006 August 2008
More informationSubstance Use And Addiction Disorders, Parts 3 & 4
Substance Use And Addiction Disorders, Parts 3 & 4 1. Medication Assisted Treatment is: a. used exclusively for marijuana addiction b. the program of choice for chronic relapses c. recommended for multiple
More informationMarijuana remains the most widely used illicit substance in the United
4 A D D I C T I O N S C I E N C E & C L I N I C A L P R A C T I C E D E C E M B E R 2 0 0 7 Marijuana Dependence and Its Treatment The prevalence of marijuana abuse and dependence disorders has been increasing
More informationWhat Works/ Effective Treatment: Adolescents with Substance Use and Co-occurring Mental Health Disorders
What Works/ Effective Treatment: Adolescents with Substance Use and Co-occurring Mental Health Disorders Randolph D. Muck, M.Ed. Advocates for Youth and Family Behavioral Health Treatment, LLC Most Programs
More informationApplying Behavioral Theories of Choice to Substance Use in a Sample of Psychiatric Outpatients
Psychology of Addictive Behaviors 1999, Vol. 13, No. 3,207-212 Copyright 1999 by the Educational Publishing Foundation 0893-164X/99/S3.00 Applying Behavioral Theories of Choice to Substance Use in a Sample
More informationMOTIVATIONAL INCENTIVES FOR ENHANCED DRUG ABUSE RECOVERY: DRUG FREE CLINICS
NIDA-CTN-0006 MOTIVATIONAL INCENTIVES FOR ENHANCED DRUG ABUSE RECOVERY: DRUG FREE CLINICS Maxine Stitzer, Ph.D., Lead Investigator Nancy Petry, Ph.D. Co-Lead Investigator Robert Brooner, Ph.D. Co-Investigator
More informationContingency Management with Adolescents and Their Families
+ Contingency Management with Adolescents and Their Families Evidencebased approach for treating adolescent substance abuse Promotes positive behaviors and addresses ambivalence Strength- Based, Family-
More informationIMPACT OF INCLUSION/ EXCLUSION CRITERIA ON ENROLLMENT
2014 CTN Web Seminar Series IMPACT OF INCLUSION/ EXCLUSION CRITERIA ON ENROLLMENT Presented by: Robert Lindblad, MD & Gaurav Sharma, PhD NIDA Clinical Coordinating & Data and Statistics Centers The EMMES
More informationEFFECTIVE PROGRAM PRINCIPLES MATRIX
Page 1 of 6 EFFECTIVE PROGRAM PRINCIPLES MATRIX (Portions taken from National Institute on Drug Abuse) The purpose of this Effective Program Principles Matrix is to provide a framework for bidders to describe
More informationNational Institute on Drug Abuse
National Institute on Drug Abuse Community Epidemiology Work Group (CEWG) NIDA Community Epidemiology Work Group 62 nd Semi- Annual Meeting June 2007 Seattle Honolulu Jim Hall Center for the Study and
More informationCannabis Use Disorders: Using Evidenced Based Interventions to Engage Students in Reducing Harmful Cannabis Use or Enter Recovery
Cannabis Use Disorders: Using Evidenced Based Interventions to Engage Students in Reducing Harmful Cannabis Use or Enter Recovery Lisa Laitman MSEd, LCADC Rutgers, The State University of New Jersey National
More informationApplying Mobile Technology to Mental Health and Substance Use Disorders: The State of the Science
Applying Mobile Technology to Mental Health and Substance Use Disorders: The State of the Science Lisa A. Marsch, PhD Director, Dartmouth Center for Technology and Behavioral Health Director, Northeast
More informationThe Value of Engagement in Substance Use Disorder (SUD) Treatment
The Value of Engagement in Substance Use Disorder (SUD) Treatment A Report from Allegheny HealthChoices, Inc. June 2016 Introduction When considering substance use disorder (SUD) treatment, the length
More informationTechnology-Based Models for Substance Abuse Treatment Delivery: Lessons Learned
Technology-Based Models for Substance Abuse Treatment Delivery: Lessons Learned Lisa A. Marsch, Ph.D. Director, Center for Technology and Health (CTH), National Development & Research Institutes (NDRI)
More informationGORDON CONWELL THEOLOGICAL SEMINARY - CHARLOTTE CO709:
GORDON CONWELL THEOLOGICAL SEMINARY - CHARLOTTE CO709: Counseling in Addictive Behaviors Fall 2010 September 10-11, October 8-9, November 5-6 Professor: John F. Cattich, Ph.D., M.Div. COURSE DESCRIPTION:
More informationPsychosocial Treatments for Opioid Use Disorder Overview
Psychosocial Treatments for Opioid Use Disorder Overview Nalan Ward, MD Director Outpatient Addiction Services Department of Psychiatry Massachusetts General Hospital *Images used for educational purposes
More informationAlcohol and Drug Abuse Services Client Demographics and Treatment Outcomes
and Drug Abuse Services Client Demographics and Treatment Outcomes Based on California Outcomes Measurement System - Treatment (26 28) Prepared by: Curtis J. Condon, PhD Alaka Nafday, MS, MSc Samantha
More informationEffects of reducing contingency management values on heroin and cocaine use for buprenorphine- and desipramine-treated patients
Blackwell Science, LtdOxford, UKADDAddiction1360-0443 2003 Society for the Study of Addiction to Alcohol and Other Drugs98665671Original ArticleContingency management and desipramine for cocaine Thomas
More informationEffectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use. Chad Morris, PhD March 7, 2018
Effectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use Chad Morris, PhD March 7, 2018 2018 BHWP Behavioral Causes of Death in U.S. 2018 BHWP 2018 BHWP Health Disparities Population Behavioral
More informationEconomic Study Estimates Meth Abuse Costs the U.S. $23.4 Billion
Economic Study Estimates Meth Abuse Costs the U.S. $23.4 Billion Washington, D.C. February 4, 2009 A RAND Corporation study released today, The Economic Cost of Methamphetamine Use in the United States,
More informationA National Portrait of Treatment in the Criminal Justice System
A National Portrait of Treatment in the Criminal Justice System SAMHSA Criminal and Juvenile Justice Matrix Workgroup January 8, 2009 Faye S. Taxman, Ph.D. Professor George Mason University Center for
More informationISAP. News. Welcome to the ISAP News. UCLA Integrated Substance Abuse Programs. Inside
UCLA Integrated Substance Abuse Programs ISAP News Welcome to the Volume 1, Issue 1 May 2003 What do the following have in common: prisons in California; medical clinics in the Gaza Strip; the UCLA Neuropsychiatric
More informationMethamphetamine Increases, and HIV Decreases, Brain Volumes
NIDA - Publications - NIDA Notes - Vol. 20, No. 6 - Research Findings of 4 http://archives.drugabuse.gov/nida_notes/nnvol20n6/increases.html NIDA Home > Publications > NIDA Notes > Vol. 20, No. 6 > Research
More informationORGANIZATION OF AMERICAN STATES INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION RECOVERY-ORIENTED SYSTEMS OF CARE
ORGANIZATION OF AMERICAN STATES INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION FORTY-FOURTH REGULAR SESSION November 19-21, 2008 Santiago, Chile OEA/Ser.L/XIV.2.44 CICAD/doc.1687/08 13 November 2008 Original:
More informationAlcoholism has been demonstrated to have a genetic component, especially among men.
Causes and Treatment of Substance-Related Disorders (Chapter 10) Familial and Genetic Influences Alcoholism has been demonstrated to have a genetic component, especially among men. Seems to be a common
More informationFY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine
FY17 SCOPE OF WORK TEMPLATE Name of Program/Services: Medication-Assisted Treatment: Buprenorphine Procedure Code: Modification of 99212, 99213 and 99214: 99212 22 99213 22 99214 22 Definitions: Buprenorphine
More informationFoundations of Addictions
Foundations of Addictions Week 8 Glenn Maynard, LPC Addiction as a maladaptive behavior This approach is grounded in psychology Model comes from classical conditioning, operative conditioning and social
More informationAre Drug Treatment Programs in Prison Effective in Reducing Recidivism Rates?
Sacred Heart University DigitalCommons@SHU Academic Festival Apr 20th, 1:00 PM - 3:00 PM Are Drug Treatment Programs in Prison Effective in Reducing Recidivism Rates? Kallysta Tanguay Sacred Heart University
More informationCoolmine Therapeutic Community
Coolmine Therapeutic Community The Implementation of CRA, an Evidence Based Practice, within Coolmine Therapeutic Community Paul Conlon, Chief Executive. 4 th November 2011. Presentation contents Range
More information